Perspective Therapeutics, Inc.CATXNYSE
Loading
Stockholders Equity Over TimeContracting
Percentile Rank93
3Y CAGR+55.9%
5Y CAGR+74.6%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+55.9%/yr
vs +63.3%/yr prior
5Y CAGR
+74.6%/yr
Recent deceleration
Acceleration
-7.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
16.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$207.03M-28.8%
2024$290.67M+286.6%
2023$75.18M+37.6%
2022$54.64M-15.1%
2021$64.39M+404.1%
2020$12.77M+123.2%
2019$5.72M-25.5%
2018$7.68M+52.7%
2017$5.03M-52.6%
2016$10.60M-